Ash Stevens Inc. Certified Compliant with SOCMA's Chemstewards Program
Detroit – January 23, 2009 – Ash Stevens Incorporated (ASI) has completed program requirements for and is now certified as compliant with SOCMA's ChemStewards® program. ChemStewards® is SOCMA's flagship environmental, health, safety and security (EHS&S) continuous performance improvement program. ChemStewards was created from industry's commitment to reducing the environmental footprint left by member's facilities. Industry created ChemStewards to meet the unique needs of the batch, custom and specialty chemical industry. As a mandatory requirement for SOCMA members engaged in the manufacturing or handling of synthetic and organic chemicals, ChemStewards is helping participants reach for superior EHS&S performance.
"ChemStewards certification sends a strong message to our employees and our community that Ash Stevens is committed to a safe and environmentally friendly operation. It gives our customers the assurance that we are committed to compliance with all applicable federal EHS&S regulations at our facility. This dovetails very nicely with the recent addition of a process safety laboratory here at Ash Stevens," said Dr. Stephen Munk, company president and CEO.
"Ash Stevens should be proud to be ChemStewards certified," said Joe Acker, SOCMA's President. "Their customers can rest assured that their business is being handled by a company that makes sound environmental, health, safety and security management a top priority. SOCMA's ChemStewards Program is the only EHS&S program designed specifically for the batch, custom and specialty chemical industry. Ash Stevens' participation indicates their commitment to compliance with federal regulation and building cooperation throughout the supply chain."
As an established contractor, ASI has been conducting process development and manufacturing of APIs in Michigan since the 1960s, and has developed substantial expertise in high-potency Active Pharmaceutical Ingredients (HPAPI), including cancer drugs. With more than 40 years of custom drug manufacturing experience, ASI has emerged as a premier contract research organization for developing highly potent anticancer agents. ASI's success in the industry stems from a goal-oriented, nimble research and development approach coupled with attention to detail and regulatory compliance programs. Today, the company has 11 FDA approvals for manufacturing.
ASI has invested more than $15 million in its manufacturing facility located in Riverview, Mich. over the past five years. These improvements have expanded the company's capabilities while integrating new technology creating a safe, effective product development and manufacturing processes. In addition, ASI has diversified its customer base while growing science-related jobs in Michigan.
About Ash Stevens, Inc.
Headquartered in Detroit, Ash Stevens, Inc. (ASI) was founded in 1962 to service the
chemical research needs of the Federal Government. ASI has extensive experience in
the development and scale-up of commercial cancer APIs and shares a longstanding
and successful relationship with the National Cancer Institute. ASI has a total of 11 FDA
approved drug substances in its portfolio. The company has more than 60 employees
and holds a variety of patents covering topics including medicinal agents and
manufacturing processes. For more information, visit www.ashstevens.com.
To download a PDF version please, click here.